FDA’s Bond Increases Intra-Agency Liaison Role
This article was originally published in The Pink Sheet Daily
FDA Director of Scientific Policy Development Susan Bond will assume a greater role in intra-agency communications.
You may also be interested in...
Associate Commissioner for External Relations Peter Pitts will join the public relations firm Manning, Selvage & Lee as VP-health affairs. During his 14-month tenure at FDA, the agency adopted a more aggressive communications approach.
FDA is implementing a three-deputy commissioner structure on an acting basis to ensure a smooth transition. Selection of a permanent commissioner is unlikely before the November elections.
Pink Sheet reporters and editor discuss the influence of the emergency use authorization on FDA decisions, another twist in the march-in rights debate, and how CBER is not using the real-time oncology review program.